XML 101 R85.htm IDEA: XBRL DOCUMENT v3.22.4
Equity (Details)
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 15, 2023
$ / shares
Jan. 03, 2023
$ / shares
Nov. 02, 2022
$ / shares
Jul. 27, 2022
$ / shares
May 04, 2022
$ / shares
Apr. 01, 2022
$ / shares
Feb. 16, 2022
$ / shares
Jan. 03, 2022
$ / shares
Jul. 31, 2021
USD ($)
shares
Apr. 30, 2021
USD ($)
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
Vote
$ / shares
shares
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Dec. 31, 2019
shares
Dec. 31, 2018
shares
Dec. 31, 2017
shares
Nov. 30, 2022
shares
Common stock                                    
Proceeds from issuance of shares under public offering | $                       $ 408,735,000 $ 514,593,000 $ 183,585,000        
Number of shares authorized                       500,000,000 500,000,000          
Noncontrolling Interest                                    
Preferred stock, par value (in dollars per share) | $ / shares                       $ 0.01 $ 0.01          
Amount available for repurchase | $                       $ 96,100,000            
Preferred Stock                                    
Proceeds from issuance of preferred stock | $                       $ 77,522,000 $ 555,999,000          
Percentage of dividend paid to common stock and preferred stock shareholders represented ordinary income to our stockholders                       100.00% 100.00% 100.00%        
Employee compensation and benefits                                    
Deferred Compensation                                    
Share-based compensation expense | $                       $ 14,200,000 $ 9,300,000 $ 8,600,000        
Selling and administrative expense                                    
Deferred Compensation                                    
Share-based compensation expense | $                       800,000 600,000 $ 500,000        
Restricted common stock                                    
Deferred Compensation                                    
Total grant date fair value | $                       21,300,000 $ 17,100,000          
Unrecognized compensation cost | $                       $ 9,000,000.0            
Remaining weighted-average vesting period                       1 year 10 months 24 days            
Restricted stock vested with grant date fair value (in shares)                       1,070,248            
Unvested restricted common stock outstanding                       1,389,427 1,257,199          
Restricted stock vested during the period, grant date fair value | $                       $ 12,000,000.0            
Restricted common stock | Chief executive officer                                    
Deferred Compensation                                    
Grants during the period (in shares)                           45,928        
Total grant date fair value | $                           $ 500,000        
Restricted common stock | Employees                                    
Deferred Compensation                                    
Grants during the period (in shares)                       652,596            
Total grant date fair value | $                       $ 11,100,000   $ 3,400,000        
Number of shares issued in net settlement                           314,957        
Restricted common stock | Employees | 2020 Plan                                    
Deferred Compensation                                    
Grants during the period (in shares)                         384,758          
Total grant date fair value | $                         $ 6,400,000          
Restricted common stock | Employees | Vested on grant date | 2020 Plan                                    
Deferred Compensation                                    
Grants during the period (in shares)                       232,899 144,951          
Total grant date fair value | $                       $ 4,000,000.0 $ 2,400,000          
Restricted common stock | Employees | First anniversaries | 2020 Plan                                    
Deferred Compensation                                    
Grants during the period (in shares)                         101,475          
Total grant date fair value | $                       $ 3,700,000 $ 1,700,000          
Restricted common stock | Employees | Second anniversaries | 2020 Plan                                    
Deferred Compensation                                    
Grants during the period (in shares)                       181,968 88,788          
Total grant date fair value | $                       $ 3,100,000 $ 1,500,000          
Restricted common stock | Employees | Third anniversaries | 2020 Plan                                    
Deferred Compensation                                    
Grants during the period (in shares)                       9,951 25,479          
Total grant date fair value | $                       $ 200,000 $ 400,000          
Restricted common stock | Employees | Fourth anniversaries | 2020 Plan                                    
Deferred Compensation                                    
Grants during the period (in shares)                       9,938 24,065          
Total grant date fair value | $                       $ 200,000 $ 400,000          
Restricted stock units (RSUs) | Director | 2020 Plan                                    
Deferred Compensation                                    
Grants during the period (in shares)                       25,012            
Total grant date fair value | $                       $ 400,000            
Restricted stock units (RSUs) | Chief executive officer | 2020 Plan                                    
Deferred Compensation                                    
Grants during the period (in shares)                       189,873            
Total grant date fair value | $                       $ 3,300,000            
Restricted stock units (RSUs) | Employees | First anniversaries                                    
Deferred Compensation                                    
Grants during the period (in shares)                       217,840            
Performance-based restricted stock | Chief executive officer                                    
Deferred Compensation                                    
Grants during the period (in shares)                       381,503         357,569  
Total grant date fair value | $                           $ 100,000        
Restricted stock vested during period (in shares)                         448,980 421,348        
Vesting period (in years)                       4 years 4 years 4 years        
Performance-based restricted stock | Chief executive officer | Maximum                                    
Deferred Compensation                                    
Grants during the period (in shares)                           275,569        
Time Based Vesting Equity Award | Chief executive officer                                    
Deferred Compensation                                    
Grants during the period (in shares)                 165,746 184,729                
Total grant date fair value | $                 $ 3,000,000.0 $ 3,100,000                
Series E preferred stock                                    
Preferred Stock                                    
Return on the preferred shares issued to third parties by its subsidiary REIT (as a percent)                       6.25% 6.25%          
Series F preferred stock                                    
Preferred Stock                                    
Return on the preferred shares issued to third parties by its subsidiary REIT (as a percent)                       6.25% 6.25%          
Common Stock                                    
Common stock                                    
Issued price per share (in dollars per share) | $ / shares                     $ 16.57              
Number of common stock sold (in shares)                       26,335,788 (29,140,369) 14,790,121        
Number of shares purchased                         (1,962,499) (2,285,178)        
Noncontrolling Interest                                    
Amount authorized under the Stock repurchase program | $                       $ 100,000,000.0            
Distributions                                    
Cash dividend declared (in dollars per share) | $ / shares $ 0.40   $ 0.40 $ 0.39 $ 0.38   $ 0.37                      
Common Stock | Director                                    
Deferred Compensation                                    
Total grant date fair value | $                           $ 500,000        
Number of shares issued in net settlement                           52,735        
Common Stock | Chief executive officer                                    
Deferred Compensation                                    
Restricted stock vested during period, net settled (in shares)                       120,665 150,530 182,467        
Preferred Stock | 6.375%Series D Preferred Stock                                    
Distributions                                    
Cash dividend declared on redeemable preferred stock (in dollars per share) | $ / shares   $ 0.3984375 0.3984375 0.3984375   $ 0.3984375   $ 0.3984375                    
Preferred Stock | Series E preferred stock                                    
Common stock                                    
Number of common stock sold (in shares)                         5,750,000          
Distributions                                    
Cash dividend declared on redeemable preferred stock (in dollars per share) | $ / shares   $ 0.390625 0.390625 0.390625   0.390625   0.390625                    
Preferred Stock                                    
Preferred stock dividend, fixed rate                         6.25%          
Preferred Stock | Series F preferred stock                                    
Common stock                                    
Number of common stock sold (in shares)                       3,292,000 8,050,000          
Distributions                                    
Cash dividend declared on redeemable preferred stock (in dollars per share) | $ / shares     $ 0.390625 $ 0.390625   $ 0.390625   $ 0.46875                    
Preferred Stock                                    
Proceeds from issuance of preferred stock | $                     $ 77,100,000              
Operating Partnership Units                                    
Noncontrolling Interest                                    
Conversion ratio for operating partnership units to common stock shares                       1            
Operating Partnership Units | Special voting preferred shares                                    
Noncontrolling Interest                                    
Preferred stock, par value (in dollars per share) | $ / shares                       $ 0.01            
Number of vote per share of Special Voting Preferred Shares | Vote                       1            
OP units outstanding (in shares)                       16,293,589            
Voting power of outstanding stock (as a percent)                       8.40%            
ACM Acquisition | Performance-based restricted stock | Chief executive officer                                    
Deferred Compensation                                    
Grants during the period (in shares)                           313,152 246,508 294,985 357,569  
Total grant date fair value | $                           $ 2,900,000        
Vesting period (in years)                           3 years        
ACM Acquisition | Common Stock | Chief executive officer                                    
Deferred Compensation                                    
Grants during the period (in shares)                       381,503            
Restricted stock vested during period (in shares)                         448,980 421,348        
Restricted stock vested during period, net settled (in shares)                       186,772 229,083 215,014        
Public offering | Common Stock                                    
Common stock                                    
Proceeds from issuance of shares under public offering | $                     $ 123,700,000              
Public offering | Preferred Stock | 6.375%Series D Preferred Stock                                    
Preferred Stock                                    
Issuance of preferred stock (in shares)                         9,200,000          
Public offering | Preferred Stock | Series E preferred stock                                    
Preferred Stock                                    
Issuance of preferred stock (in shares)                         5,750,000          
Return on the preferred shares issued to third parties by its subsidiary REIT (as a percent)                         6.375%          
Public offering | Preferred Stock | Series F preferred stock                                    
Preferred Stock                                    
Issuance of preferred stock (in shares)                     3,292,000   8,050,000          
Return on the preferred shares issued to third parties by its subsidiary REIT (as a percent)                     6.25%   6.25%          
At-The-Market | Common Stock                                    
Common stock                                    
Number of shares available under the amended agreement                       18,290,000           25,000,000
Number of common stock sold (in shares)                     7,475,000              
Proceeds from issuance of shares under public offering | $                       $ 285,000,000.0            
Preferred Stock                                    
Proceeds from issuance of preferred stock | $                       $ 18,860,788